Conner James R, Hornick Jason L
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Adv Anat Pathol. 2015 May;22(3):149-67. doi: 10.1097/PAP.0000000000000069.
Carcinoma of unknown primary origin (CUP) is one of the 10 most prevalent malignancies. CUP patients in whom a site of origin can be ascribed have better outcomes than those in which the primary tumor remains unidentified. Among the tools available to pathologists in approaching these lesions, immunohistochemistry is a reliable, inexpensive, and widely available resource. New markers continue to emerge, which, in combination with other historically useful antibodies, allow rapid and accurate identification of primary site in an increasing number of cases. This review discusses the approach to the diagnosis of CUP using immunohistochemistry and outlines some of the most useful markers with a particular focus on the utility of lineage-restricted transcription factors, including CDX2, NKX3-1, PAX8, SATB2, TTF-1, and SF1.
原发灶不明癌(CUP)是最常见的10种恶性肿瘤之一。能够明确原发部位的CUP患者比原发肿瘤仍未明确的患者预后更好。在病理学家处理这些病变时可用的工具中,免疫组织化学是一种可靠、廉价且广泛可用的资源。新的标志物不断涌现,与其他历来有用的抗体相结合,能够在越来越多的病例中快速准确地识别原发部位。本综述讨论了使用免疫组织化学诊断CUP的方法,并概述了一些最有用的标志物,特别关注谱系限制转录因子的效用,包括尾型同源盒转录因子2(CDX2)、NK3转录因子1(NKX3-1)、配对盒基因8(PAX8)、特殊AT富含序列结合蛋白2(SATB2)、甲状腺转录因子1(TTF-1)和类固醇生成因子1(SF1)。